Economics at your fingertips  

Effective Foreign Aid: Evidence from Gavi’s Vaccine Program

Gauri Shastry and Daniel Tortorice ()

No 2102, Working Papers from College of the Holy Cross, Department of Economics

Abstract: Gavi, the Vaccine Alliance has provided over US$13 billion in funding for vaccination expansion in low-income countries since its founding in 1999. We exploit the differential timing in Gavi support across countries and vaccines to estimate the program’s effects. We find that, on average, Gavi’s support of a vaccine increased coverage rates by 3 percentage points and reduced child mortality from related causes by between 0.5 and 2 children per 1,000 live births. We estimate these improvements saved between 825,000 and 3.3 million lives at a cost ranging from US $3,940 to US $15,757 per life saved. Given the relatively low cost of Gavi’s programs, we argue that Gavi represents a particularly effective form of foreign aid. As Gavi’s programs are tightly linked to desirable development outcomes and can be rigorously evaluated, our results provide support for the broader notion that careful structuring of foreign aid programs can be substantially beneficial for low-income countries.

Keywords: Foreign Aid; Health, Development; Vaccination (search for similar items in EconPapers)
JEL-codes: F35 I15 O1 (search for similar items in EconPapers)
Pages: 49 pages
Date: 2021-02
New Economics Papers: this item is included in nep-dev
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed

Downloads: (external link) (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link:

Access Statistics for this paper

More papers in Working Papers from College of the Holy Cross, Department of Economics Contact information at EDIRC.
Bibliographic data for series maintained by Victor Matheson ().

Page updated 2023-02-02
Handle: RePEc:hcx:wpaper:2102